Treatment and outcomes for patients with relapsed or refractory diffuse large B-cell lymphoma: a contemporary, nationwide, population-based study in the Netherlands

被引：0
|
作者：
Elise R. A. Pennings
Müjde Durmaz
Otto Visser
Eduardus F. M. Posthuma
Djamila E. Issa
Martine E. D. Chamuleau
Pieternella J. Lugtenburg
Marie José Kersten
Avinash G. Dinmohamed
机构：
[1] Amsterdam UMC location University of Amsterdam,Department of Hematology
[2] Cancer Center Amsterdam,Erasmus School of Health Policy and Management
[3] LYMMCARE (Lymphoma and Myeloma Center Amsterdam),Department of Research and Development
[4] Erasmus University Rotterdam,Department of Registration
[5] Netherlands Comprehensive Cancer Organisation (IKNL),Department of Hematology
[6] Netherlands Comprehensive Cancer Organisation (IKNL),Department of Internal Medicine
[7] Leiden University Medical Center,Department of Internal Medicine
[8] Reinier de Graaf Gasthuis,Department of Hematology
[9] Jeroen Bosch Hospital,Department of Hematology
[10] Amsterdam UMC location Vrije Universiteit Amsterdam,Department of Public Health
[11] Erasmus MC Cancer Institute,undefined
[12] University Medical Center Rotterdam,undefined
[13] Erasmus MC,undefined
[14] University Medical Center Rotterdam,undefined
来源：
Blood Cancer Journal | / 14卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] New and emerging therapies for the treatment of relapsed/refractory diffuse large B-cell lymphoma
    Moore, Donald C.
    Peery, Matthew R.
    Tobon, Katherine A.
    Raheem, Farah
    Hwang, Grace S.
    Alhennawi, Lin
    Hughes, Mitchell E.
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2022, 28 (08) : 1848 - 1858
  • [22] Cardiovascular mortality among patients with diffuse large B-cell lymphoma: a population-based study
    Hong, Danhua
    Yin, Mengzhuo
    Li, Jie
    Deng, Zhiyong
    Ren, Zhilei
    Zhou, Yun
    Huang, Shuijin
    Yan, Xuejun
    Zhong, Weijie
    Liu, Feng
    Yang, Chongzhe
    LEUKEMIA & LYMPHOMA, 2024, 65 (11) : 1634 - 1644
  • [23] TREATMENT PREFERENCES AMONG PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA IN THE UNITED STATES
    Liu, F. F.
    Collacott, H.
    Clarke, H.
    Michaels-Igbokwe, C.
    VALUE IN HEALTH, 2023, 26 (06) : S316 - S316
  • [24] TREATMENT PATTERNS AND COST ANALYSIS AMONG PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA
    Nabhan, C.
    Myerscough, C.
    Kish, J.
    Chung, J.
    Chopra, D.
    VALUE IN HEALTH, 2019, 22 : S82 - S82
  • [25] Bendamustine plus Rituximab as Treatment for Elderly Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma
    Vacirca, Jeffrey
    Tabbara, Imad
    Acs, Peter
    Shumaker, Grace
    BLOOD, 2010, 116 (21) : 1157 - 1157
  • [26] Current options and future perspectives in the treatment of patients with relapsed/refractory diffuse large B-cell lymphoma
    Frontzek, Fabian
    Karsten, Imke
    Schmitz, Norbert
    Lenz, Georg
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2022, 13
  • [27] Incidence of relapsed/refractory diffuse large B-cell lymphoma (DLBCL) including CNS relapse in a population-based cohort of 4243 patients in Sweden
    Sara Harrysson
    Sandra Eloranta
    Sara Ekberg
    Gunilla Enblad
    Mats Jerkeman
    Bjorn E. Wahlin
    Per-Ola Andersson
    Karin E. Smedby
    Blood Cancer Journal, 11
  • [28] Incidence of Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) Including CNS Relapse in a Population-Based Cohort of 4205 Patients in Sweden
    Harrysson, Sara
    Eloranta, Sandra
    Ekberg, Sara
    Enblad, Gunilla
    Jerkeman, Mats
    Hasselblom, Sverker
    Wahlin, Bjorn E.
    Andersson, Per-Ola
    Smedby, Karin E.
    BLOOD, 2019, 134
  • [29] Polatuzumab vedotin in relapsed/refractory diffuse large B-cell lymphoma
    Dietliker, N.
    Kiesel, H.
    Mueller, R.
    Mueller, A. M.
    Manz, M. G.
    Zenz, T.
    Rosler, W.
    SWISS MEDICAL WEEKLY, 2020, : 21S - 21S
  • [30] Incidence of relapsed/refractory diffuse large B-cell lymphoma (DLBCL) including CNS relapse in a population-based cohort of 4243 patients in Sweden
    Harrysson, Sara
    Eloranta, Sandra
    Ekberg, Sara
    Enblad, Gunilla
    Jerkeman, Mats
    Wahlin, Bjorn E.
    Andersson, Per-Ola
    Smedby, Karin E.
    BLOOD CANCER JOURNAL, 2021, 11 (01)
12345